CAM
AMRX icon

Congress Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Congress Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$30.7M Buy
1,524,355
+741,577
+95% +$13.4M 0.2% 124
2026
Q2 		$13.5M Buy
+782,778
New +$10.7M 0.08% 188

Other funds holding AMRX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
SFGP
Stonebridge Financial Group (Pennsylvania) Wormleysburg, Pennsylvania $1.36B AUM 14.31% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Congress Asset Management's AMRX Position: Q3 2026 in Review

Congress Asset Management increased its Amneal Pharmaceuticals (AMRX) stake by 95% in Q3 2026, buying an estimated $13.4M and bringing the position to 1,524,355 shares worth $30.7M. The position accounts for 0.2% of the portfolio, ranked #124.

Congress Asset Management first reported a position in AMRX in Q2 2026 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Congress Asset Management held 1,524,355 shares of Amneal Pharmaceuticals worth $30.7M as of Q3 2026.
  • Congress Asset Management bought 741,577 Amneal Pharmaceuticals shares in Q3 2026, an estimated $13.4M.
  • Amneal Pharmaceuticals made up 0.2% of Congress Asset Management's portfolio in Q3 2026, its #124 holding.
  • Congress Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Congress Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.